ID   EO-NY
AC   CVCL_A2HI
SY   EONY#17
DR   Wikidata; Q105506844
RX   PubMed=28301575;
RX   PubMed=31519152;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17234; ANKRD30A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR23 ! EO771
SX   Female
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=28301575; DOI=10.1371/journal.pone.0174077; PMCID=PMC5354463;
RA   Das K., Eisel D., Lenkl C., Goyal A., Diederichs S., Dickes E.,
RA   Osen W., Eichmuller S.B.;
RT   "Generation of murine tumor cell lines deficient in MHC molecule
RT   surface expression using the CRISPR/Cas9 system.";
RL   PLoS ONE 12:E0174077-E0174077(2017).
//
RX   PubMed=31519152; DOI=10.1186/s12885-019-6102-6; PMCID=PMC6743128;
RA   Das K., Eisel D., Vormehr M., Muller-Decker K., Hommertgen A.,
RA   Jager D., Zornig I., Feuerer M., Kopp-Schneider A., Osen W.,
RA   Eichmuller S.B.;
RT   "A transplantable tumor model allowing investigation of
RT   NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice.";
RL   BMC Cancer 19:914.1-914.13(2019).
//